Highlights Newsletter 5

This newsletter presents you the following key sessions:

1. PODCAST with dr. Courtney DiNardo about the VIALE-A study examining azacitidine in AML patients

2. Real-life characteristics and outcome of biopsy-proven post-transplant lymphoproliferative disorders after solid
    organ transplantation

3. Similar safety and efficacy of azacitidine and decitabine in patients with treatment-naïve acute myeloid leukaemia
    who are ineligible for intensive chemotherapy

4. Adding isatuximab to carfilzomib and dexamethasone significantly delays the disease progression of patients
    with relapsed/refractory multiple myeloma

5. Pegcetacoplan superior to eculizumab in patients with paroxysmal nocturnal haemoglobinuria